News

Filter

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial

05-06-2013

Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase…

Antibiotics and Infectious diseasesDermatologicalsFerrer InternacionalLicensingOzenoxacinPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top